Deep, qualified subsequent-era sequencing has revealed that subclonal mutations (i.e., those current in only a portion of tumor cells) may be detected for all driver genes and they are connected with fast disease development and very poor final result.11–13 This is especially suitable for TP53 mutations given the fact that, https://johnc555xgn3.win-blog.com/profile